Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded potential insights into new therapeutic approaches. Current efforts centers on targeting the underlying mechanisms of MSA. One strategy under investigation involves drug-based interventions to modulate the function of specific sign